The grades of four health care provider stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.
Magellan Health Services, Inc.’s (MGLN) grade is moving up to a B (“buy”) this week from last week’s C (“hold”). Magellan Health Services coordinates and manages the delivery of behavioral healthcare treatment services. In Portfolio Grader’s specific subcategories of Earnings Surprise and Cash Flow, MGLN also gets A’s. For more information, get Portfolio Grader’s complete analysis of MGLN stock.
Cardinal Health, Inc. (CAH) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Cardinal Health provides products and services related to the safety and productivity of healthcare. Shares of CAH have increased 9.9% over the past month, better than the 1.7% decrease the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of CAH stock.
Amedisys, Inc.’s (AMED) ratings are looking better this week, moving up to a B from last week’s C. Amedisys provides home health care and hospice services in the United States. The stock’s price of $16.20 is above the 50-day moving average of $15.51. For more information, get Portfolio Grader’s complete analysis of AMED stock.
Concord Medical Services Holding Ltd. ADR (CCM) is seeing ratings go up from a B last week to an A this week. Concord Medical Services operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. Shares of the stock have been trading at an exceptionally rapid pace, up 801.8% from the week prior. For more information, get Portfolio Grader’s complete analysis of CCM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.